Atlas Trials

Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure

Clinical trial NCT03273322 · COMPLETED

Trial details

NCT number
NCT03273322
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Atrial FibrillationAtrial AppendageHemorrhage
Start date
2017-09-13
Primary completion
2018-11-20
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.